Drug intelligence / Profile preview

3-[(4-chloroanilino)sulfonyl]thiophene-2-carboxylic acid

Development stage
Unknown
Modality
Small Molecules
01

Overview

**3-[(4-Chloroanilino)sulfonyl]thiophene-2-carboxylic acid (STC)** is a small molecule organic compound classified as a sulfanilide. It features a thiophene ring substituted with a carboxylic acid group and a sulfamoyl group derived from 4-chlorophenyl, which contributes to its unique chemical properties and potential biological activities[7]. The compound has been investigated as an inhibitor of AmpC beta-lactamase, an enzyme that confers resistance to beta-lactam antibiotics in bacteria. Specifically, it acts as a non-beta-lactam inhibitor of class C beta-lactamase AmpC (Ki = 26 μM), providing insights into overcoming antibiotic resistance mechanisms[8]. While specific pharmacological data are limited, compounds in the sulfanilide class often exhibit antimicrobial properties by interfering with folic acid synthesis; however, direct evidence for this mechanism in STC is not established[7].

Other names
3-((4-chloroanilino)sulfonyl)thiophene-2-carboxylic acid3-[(4-chlorophenyl)sulfamoyl]thiophene-2-carboxylic acid496051-23-1YPG9JNK4RXYPG-9JNK4RXYPG 9JNK4RXDTXSID20332234DTXSID-20332234DTXSID 20332234
02

Targets

AmpC (AmpC beta-lactamase)

Beyond the preview

Go deeper on 3-[(4-chloroanilino)sulfonyl]thiophene-2-carboxylic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 3-[(4-chloroanilino)sulfonyl]thiophene-2-carboxylic acid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call